Rovsing A/S
CSE:ROV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rovsing A/S
CSE:ROV
|
DK |
|
Gyldendal A/S
CSE:GYLD B
|
DK |
|
Grupo Financiero Banorte SAB de CV
OTC:GBOOY
|
MX |
|
Green Cross Health Ltd
NZX:GXH
|
NZ |
|
GMM Pfaudler Ltd
NSE:GMMPFAUDLR
|
IN |
|
S
|
Sunway International Holdings Ltd
HKEX:58
|
HK |
|
M
|
Meshek Energy-Renewable Energies Ltd
TASE:MSKE
|
IL |
|
Remy Cointreau SA
PAR:RCO
|
FR |
|
T
|
Taiwan Chelic Co Ltd
TWSE:4555
|
TW |
|
C
|
Crazy Sports Group Ltd
HKEX:82
|
CN |
|
FriendTimes Inc
HKEX:6820
|
CN |
|
Seven Principles AG
XETRA:T3T1
|
DE |
|
Beijing Wandong Medical Technology Co Ltd
SSE:600055
|
CN |
Balance Sheet
Balance Sheet Decomposition
Rovsing A/S
Rovsing A/S
Balance Sheet
Rovsing A/S
| Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
5
|
10
|
2
|
2
|
7
|
1
|
1
|
0
|
0
|
2
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
5
|
10
|
2
|
2
|
7
|
1
|
1
|
0
|
0
|
2
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
9
|
14
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
9
|
6
|
17
|
15
|
12
|
12
|
11
|
9
|
4
|
2
|
6
|
5
|
9
|
8
|
5
|
5
|
3
|
3
|
6
|
9
|
7
|
9
|
5
|
|
| Accounts Receivables |
9
|
5
|
16
|
15
|
12
|
11
|
11
|
9
|
4
|
1
|
6
|
2
|
7
|
5
|
3
|
4
|
1
|
2
|
5
|
8
|
6
|
7
|
4
|
|
| Other Receivables |
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
3
|
2
|
2
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
1
|
|
| Inventory |
1
|
0
|
0
|
0
|
9
|
15
|
8
|
3
|
1
|
1
|
3
|
6
|
4
|
5
|
9
|
7
|
11
|
6
|
5
|
7
|
8
|
9
|
11
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Current Assets |
15
|
17
|
28
|
32
|
42
|
29
|
22
|
13
|
6
|
5
|
10
|
12
|
14
|
13
|
16
|
13
|
14
|
9
|
11
|
16
|
17
|
18
|
17
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
2
|
2
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
3
|
4
|
4
|
5
|
2
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
5
|
9
|
13
|
39
|
44
|
39
|
23
|
21
|
19
|
17
|
14
|
11
|
11
|
12
|
12
|
13
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
6
|
6
|
5
|
2
|
2
|
4
|
4
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Total Assets |
15
N/A
|
17
+14%
|
29
+68%
|
33
+16%
|
45
+34%
|
31
-30%
|
29
-9%
|
24
-15%
|
21
-12%
|
25
+16%
|
54
+116%
|
60
+11%
|
57
-5%
|
41
-27%
|
41
0%
|
36
-13%
|
34
-4%
|
27
-21%
|
25
-8%
|
33
+29%
|
33
+2%
|
35
+6%
|
35
-1%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
2
|
2
|
4
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
4
|
2
|
4
|
3
|
1
|
3
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
2
|
0
|
0
|
0
|
12
|
7
|
7
|
8
|
14
|
3
|
8
|
9
|
8
|
7
|
7
|
6
|
7
|
3
|
10
|
8
|
4
|
6
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
4
|
2
|
10
|
11
|
9
|
4
|
7
|
8
|
2
|
2
|
2
|
3
|
9
|
13
|
13
|
10
|
3
|
7
|
7
|
5
|
12
|
12
|
11
|
|
| Total Current Liabilities |
6
|
6
|
14
|
13
|
12
|
18
|
18
|
18
|
15
|
21
|
8
|
16
|
20
|
25
|
23
|
18
|
12
|
15
|
11
|
19
|
24
|
20
|
21
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
5
|
6
|
3
|
5
|
4
|
|
| Deferred Income Tax |
4
|
4
|
6
|
7
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
10
N/A
|
10
+1%
|
20
+104%
|
20
+1%
|
16
-22%
|
18
+12%
|
34
+88%
|
34
+2%
|
31
-9%
|
36
+18%
|
8
-79%
|
25
+217%
|
29
+20%
|
25
-15%
|
23
-8%
|
18
-24%
|
16
-10%
|
16
-1%
|
16
-2%
|
24
+57%
|
27
+9%
|
25
-5%
|
24
-3%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
1
|
1
|
1
|
12
|
16
|
16
|
16
|
18
|
18
|
18
|
13
|
14
|
15
|
15
|
17
|
20
|
23
|
23
|
24
|
24
|
24
|
6
|
7
|
|
| Retained Earnings |
4
|
5
|
8
|
1
|
13
|
2
|
21
|
28
|
27
|
29
|
33
|
21
|
12
|
1
|
2
|
2
|
4
|
11
|
17
|
19
|
21
|
0
|
1
|
|
| Other Equity |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
5
|
5
|
|
| Total Equity |
5
N/A
|
7
+41%
|
8
+17%
|
13
+53%
|
29
+124%
|
14
-53%
|
5
N/A
|
10
-103%
|
10
+2%
|
12
-21%
|
46
N/A
|
35
-24%
|
27
-23%
|
16
-40%
|
18
+12%
|
18
0%
|
19
+2%
|
11
-38%
|
10
-16%
|
8
-16%
|
7
-18%
|
10
+54%
|
11
+6%
|
|
| Total Liabilities & Equity |
15
N/A
|
17
+14%
|
29
+68%
|
33
+16%
|
45
+34%
|
31
-30%
|
29
-9%
|
24
-15%
|
21
-12%
|
25
+16%
|
54
+116%
|
60
+11%
|
57
-5%
|
41
-27%
|
41
0%
|
36
-13%
|
34
-4%
|
27
-21%
|
25
-8%
|
33
+29%
|
33
+2%
|
35
+6%
|
35
-1%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|